Iovance Biotherapeutics, Inc. Common Stock (IOVA) is a publicly traded Healthcare sector company. As of September 17, 2026, IOVA trades at $9.99 with a market cap of $4.24B and a P/E ratio of -5.15. IOVA moved +1.22% today. Year to date, IOVA is +261.54%; over the trailing twelve months it is +329.13%. Its 52-week range spans $1.64 to $9.93. Analyst consensus is buy with an average price target of $9.14. Rallies surfaces IOVA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
7 analysts cover IOVA: 0 strong buy, 5 buy, 2 hold, 0 sell, and 0 strong sell. The consensus rating is buy. The average price target is $9.14.
| Metric | Value |
|---|---|
| Price | $9.99 |
| Market Cap | $4.24B |
| P/E Ratio | -5.15 |
| EPS | $-1.89 |
| Dividend Yield | 0.00% |
| 52-Week High | $9.93 |
| 52-Week Low | $1.64 |
| Volume | 16.79K |
| Avg Volume | 0 |
| Revenue (TTM) | $1.19M |
| Net Income | $-444.04M |
| Gross Margin | -804.54% |
7 analysts cover IOVA: 0 strong buy, 5 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $9.14.